These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10205989)
1. Ethosuximide inducted changes in the gastro-intestinal tract. Zagorchev P; Sirakov V; Uchikov A; Sirakov N Folia Med (Plovdiv); 1998; 40(3B Suppl 3):28-33. PubMed ID: 10205989 [TBL] [Abstract][Full Text] [Related]
2. The ethosuximide-induced hyperpolarization of smooth muscle tissues--a cause of functional changes in the gastrointestinal tract of rats--is provoked by CA(2+)-dependent K(+)-efflux. Kristev A; Sirakov V; Kostadinova I; Lukanov J Folia Med (Plovdiv); 1994; 36(4):13-22. PubMed ID: 8698280 [TBL] [Abstract][Full Text] [Related]
3. Roentgenographic study of ethosuximide-induced functional changes in rat gastrointestinal tract and their modulation by Nivalin in a chronic experiment. Sirakov V; Kostadinova I; Velkova K; Kristev A Folia Med (Plovdiv); 1998; 40(4):71-7. PubMed ID: 10371804 [TBL] [Abstract][Full Text] [Related]
4. Ethosuximide treatment of petit mal seizures. A study of 87 pediatric patients. Weinstein AW; Allen RJ Am J Dis Child; 1966 Jan; 111(1):63-7. PubMed ID: 4954419 [No Abstract] [Full Text] [Related]
5. [Ethosuximide in treatment of petit mal epilepsy]. Kiehi Y; Ando J No To Shinkei; 1965 Aug; 17(8):831-40. PubMed ID: 4957471 [No Abstract] [Full Text] [Related]
6. Neostigmine, but not metoclopramide, abolishes ethosuximide-induced functional gastrointestinal disturbances. Sirakov V; Krastev A; Kostadinova I; Turiiski V Pharmacology; 2005 Dec; 75(4):187-94. PubMed ID: 16210879 [TBL] [Abstract][Full Text] [Related]
7. [Possibility for provoking grand mal series in ethosuximide therapy--2 case reports]. Findeis B Psychiatr Neurol Med Psychol (Leipz); 1990 Sep; 42(9):576-7. PubMed ID: 2126870 [No Abstract] [Full Text] [Related]
8. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Brigo F; Igwe SC Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003032. PubMed ID: 28195639 [TBL] [Abstract][Full Text] [Related]
9. Ethosuximide-induced conversion of typical childhood absence to Rolandic spikes. Anyanwu C; Ghavami F; Schuelein M; Motamedi GK J Child Neurol; 2013 Jan; 28(1):111-4. PubMed ID: 22467741 [TBL] [Abstract][Full Text] [Related]
10. Ethosuximide-associated lupus with cerebral and renal manifestations. Casteels K; Van Geet C; Wouters K Eur J Pediatr; 1998 Sep; 157(9):780. PubMed ID: 9776542 [No Abstract] [Full Text] [Related]
11. Ethosuximide: from bench to bedside. Gören MZ; Onat F CNS Drug Rev; 2007; 13(2):224-39. PubMed ID: 17627674 [TBL] [Abstract][Full Text] [Related]
12. [ETHOSUXIMIDE (ZARONDAN) IN THE TREATMENT OF PETIT MAL EPILEPSY AND RELATED SEIZURES]. PALUDAN J; KIORBOE E; TROLLE E; OVERVAD E Ugeskr Laeger; 1964 Feb; 126():201-3. PubMed ID: 14139861 [No Abstract] [Full Text] [Related]
13. ZARONTIN (ETHOSUXIMIDE) IN THE TREATMENT OF PETIT MAL AND RELATED DISORDERS. KIORBOE E; PALUDAN J; TROLLE E; OVERVAD E Epilepsia; 1964 Mar; 5():83-9. PubMed ID: 14155209 [No Abstract] [Full Text] [Related]
14. [ZARONTIN THERAPY OF PETIT MAL EPILEPSY RESISTANT TO ANTICONVULSANTS]. PROT J; SAPER J; STROINSKA B Neurol Neurochir Psychiatr Pol; 1963; 13():487-90. PubMed ID: 14079934 [No Abstract] [Full Text] [Related]
18. [Ethosuximide in the treatment of oxazolidineresistant petit mal epilepsy]. HERRLIN KM Nord Med; 1963 Mar; 69():336-8. PubMed ID: 13954083 [No Abstract] [Full Text] [Related]